Evidence map›Paper›PMID 30192822›Full record

ArticlePloS one2018

Evaluation of cytotoxicity features of antimicrobial peptides with potential to control bacterial diseases of citrus.

Rosangela Naomi Inui Kishi, Dagmar Stach-Machado, Junya de Lacorte Singulani, Claudia Tavares Dos Santos, Ana Marisa Fusco-Almeida, Eduardo Maffud Cilli, Juliana Freitas-Astúa, Simone Cristina Picchi, Marcos Antonio Machado

Abstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Article
  2. Article
  3. Modulating Antimicrobial Activity and Structure of the Peptide Esc(1-21) via Site-Specific Isopeptide Bond Formation.Journal of peptide science : an official publication of the European Peptide Society · 2025
    Article
  4. Antimicrobial peptides in post-harvest management of fruits.Journal of food science and technology · 2025
    Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. A Synergic Potential of Antimicrobial Peptides againstMolecules (Basel, Switzerland) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Rosangela Naomi Inui KishiCentro de Citricultura Sylvio Moreira, Instituto Agronômico, Cordeirópolis, São Paulo, Brazil.ORCID 0000-0002-7313-6756
Dagmar Stach-MachadoInstituto de Biologia, Universidade Estadual de Campinas, Campinas, São Paulo, Brazil.
Junya de Lacorte SingulaniFaculdade de Ciências Farmacêuticas, Universidade Estadual Paulista Julio de Mesquita Filho, Araraquara, São Paulo, Brazil.
Claudia Tavares Dos SantosFaculdade de Ciências Farmacêuticas, Universidade Estadual Paulista Julio de Mesquita Filho, Araraquara, São Paulo, Brazil.
Ana Marisa Fusco-AlmeidaFaculdade de Ciências Farmacêuticas, Universidade Estadual Paulista Julio de Mesquita Filho, Araraquara, São Paulo, Brazil.
Eduardo Maffud CilliInstituto de Química de Araraquara, Departamento de Bioquímica e tecnologia química, Universidade Estadual Paulista Julio de Mesquita Filho, Araraquara, São Paulo, Brazil.
Juliana Freitas-AstúaEmbrapa Cassava and Fruits, Cruz das Almas, Bahia, Brazil.
Simone Cristina PicchiCentro de Citricultura Sylvio Moreira, Instituto Agronômico, Cordeirópolis, São Paulo, Brazil.
Marcos Antonio MachadoCentro de Citricultura Sylvio Moreira, Instituto Agronômico, Cordeirópolis, São Paulo, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial peptides (AMPs) can be found in various organisms, and could be considered an alternative for pesticides used to control plant pathogens, including those affecting citrus. Brazil is the largest producer and exporter of frozen concentrated orange juice in the world. However, the citrus industry has been affected by several diseases such as citrus canker and huanglongbing (HLB), caused by the bacteria Xanthomonas citri subsp. citri (X.citri) and Candidatus Liberibacter asiaticus (CaLas), respectively. In order to control these pathogens, putative AMPs were prospected in databases containing citrus sequences. Furthermore, AMPs already reported in the literature were also used for in vitro and in vivo assays against X.citri. Since CaLas cannot be cultivated in vitro, surrogates as Sinorhizobium meliloti and Agrobacterium tumefaciens were used. This study reports the evaluation of six AMPs obtained from different sources, two of them from Citrus spp. (citrus-amp1 and citrus-amp2), three from amphibians (Hylin-a1, K0-W6-Hy-a1 and Ocellatin 4-analogue) and one from porcine (Tritrpticin). Peptides K0-W6-Hy-a1, Ocellatin 4-analogue, and citrus-amp1 showed bactericidal activity against X.citri and S. meliloti and bacteriostatic effect on A. tumefaciens. These results were confirmed for X.citri in planta. In addition cytotoxicity evaluations of these molecules were performed. The AMPs that showed the lowest hemolytic activities were Triptrpticin, citrus-amp1 and citrus-amp2. Citrus-amp1 and citrus-amp2 not presented toxicity in experiments using in vivo model, G. mellonella and U87 MG cells. To verify the interaction of these AMPs with bacteria and erythrocyte cell membranes, vesicles mimicking these cells were built. Citrus-amp1 and Tritrpticin exhibited higher affinity to bacterial membranes, while Ocellatin 4-analogue and Hylin-a1 showed higher affinity to erythrocyte membranes; exclude their use in citrus. This work demonstrates an essential alternative, trough AMPs obtained from Citrus spp., which can be feasibly used to control bacterial pathogens.

Indexed as

Amino Acid SequenceAmphibiansAnimalsAnti-Infective AgentsCell Line, TumorCell SurvivalCitrusHumansMicrobial ViabilityMothsPeptidesPlant DiseasesPlant ProteinsSwineXanthomonasAnti-Infective AgentsPeptidesPlant Proteins

Identifiers

PMID30192822
PMCPMC6128562

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.